Rybelsus 14 mg · CNK 4216347

Product information

Rybelsus 14 mg
30
4216347
0 / 10
Locked

Product properties

A10BJ06
Novo Nordisk
Tablet
EU/1/20/1430/008
05712249115326
M1
Public
562320-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Replacement by another medicinal product/pack) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Different strength — dose adjustment required. Consult the physician.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 1 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

Commercialization stopped Active
- present

Replacement by another medicinal product/pack

Alternative available
Available
Until 30/04/2026

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
14 mg
910463-68-2
Excipient
23 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
154 days
4
0
01/05/2026